4.5 Article

Clinical efficacy, drug sustainability and serum drug levels in Crohn's disease patients treated with ustekinumab - A prospective, multicenter cohort from Hungary

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Ustekinumab in Crohn's disease: Real-world outcomes from the Sicilian network for inflammatory bowel diseases

Anna Viola et al.

Summary: The study evaluated the effectiveness and safety of ustekinumab in an Italian cohort of CD patients. Results showed satisfactory effectiveness and safety profile, with the majority of patients achieving steroid-free clinical remission and clinical response at 24 and 52 weeks, and a high persistence rate of 89% after 12 months of treatment.

JGH OPEN (2021)

Article Gastroenterology & Hepatology

Ustekinumab for Crohn's Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study

Vince B. C. Biemans et al.

JOURNAL OF CROHNS & COLITIS (2020)

Article Gastroenterology & Hepatology

Safety and effectiveness of ustekinumab for induction of remission in patients with Crohn's disease: A multicenter Israeli study

Ariella Bar-Gil Shitrit et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)

Article Gastroenterology & Hepatology

Real-world long-term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry

Marisa Iborra et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Article Gastroenterology & Hepatology

Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort

Clas-Goran af Bjorkesten et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease

Omoniyi J. Adedokun et al.

GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease

Paul Rutgeerts et al.

GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

Association Between Ustekinumab Trough Concentrations and Clinical, Biomarker, and Endoscopic Outcomes in Patients With Crohn's Disease

Robert Battat et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)

Article Medicine, General & Internal

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease

B. G. Feagan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Medicine, General & Internal

Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

William J. Sandborn et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Gastroenterology & Hepatology

Correlation Between the Crohn's Disease Activity and Harvey-Bradshaw Indices in Assessing Crohn's Disease Severity

Severine Vermeire et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)

Article Medicine, General & Internal

Anti-interleukin-12 antibody for active Crohn's disease

PJ Mannon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)